Safety, Tolerability and Efficacy of GcMAF in Patients With Chronic Inflammatory Diseases
Clinical trial NCT06877364 · COMPLETED
Trial details
- NCT number
- NCT06877364
- Sponsor
- S.LAB (SOLOWAYS)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2025-09-03
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.